Robbins LLP is Investigating Allegations that Moderna, Inc. (MRNA) Misled Investors Regarding the Efficacy of its RSV Vaccine…
Pfizer faced a setback with its combo Covid-flu shot, which could allow Moderna and others to gain ground. Meanwhile,…
Nach dem starken Wochenauftakt am Montag tun sich die US-Aktienmärkte am Dienstag schwer. Alle wichtigen Indizes notieren leicht im Minus.…
Nach dem starken Wochenauftakt am Montag tun sich die US-Aktienmärkte am Dienstag schwer. Alle wichtigen Indizes notieren leicht im Minus.…
Die US-Märkte haben nach einem zögerlichen Start am Montag am Ende doch noch deutlich zulegen können. Der US-Leitindex Dow Jones…
Die US-Märkte haben nach einem zögerlichen Start am Montag am Ende doch noch deutlich zulegen können. Der US-Leitindex Dow Jones…
Kulmbach (www.aktiencheck.de) - BioNTech-Aktienanalyse von "Der Aktionär":
Marion Schlegel vom Anlegermagazin "Der Aktionär" nimmt die Aktie von BioNTech SE (ISIN: US09075V1026,…
Die Aktie von BioNTech und Moderna können zum Wochenstart deutliche Zugewinne verzeichnen. Beide Werte unterstützt die jüngste Entwicklung zu Corona…
Die Aktie von BioNTech und Moderna können zum Wochenstart deutliche Zugewinne verzeichnen. Beide Werte unterstützt die jüngste Entwicklung zu Corona…
A clinical-trial failure for Pfizer and BioNTech means Moderna is leading the race to develop a combo shot for the…
A clinical-trial failure for Pfizer and BioNTech means Moderna is leading the race to develop a combo shot for the…
NEW YORK, Aug. 18, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights…
NEW YORK, Aug. 18, 2024 (GLOBE NEWSWIRE) -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC, a nationally…
NEW YORK, Aug. 16, 2024 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law…
New York (www.aktiencheck.de) - Rating-Update:
J.P. Morgan Securities stuft die Aktie von Moderna Inc. (ISIN: US60770K1079, WKN: A2N9D9, Ticker-Symbol: 0QF, NASDAQ-Symbol:…
NEW YORK, Aug. 14, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights…
Robbins LLP is Investigating Allegations that Moderna, Inc. (MRNA) Misled Investors Regarding the Efficacy of its RSV Vaccine…
Pfizer and Moderna’s updated vaccines will be available for people six months and older, while Novavax’s vaccine will be aimed…
Minneapolis (www.aktiencheck.de) - Rating-Update:
Edward Tenthoff, Analyst von Piper Sandler, bewertet die Aktie von Moderna Inc. (ISIN: US60770K1079, WKN: A2N9D9, Ticker-Symbol:…
Kulmbach (www.aktiencheck.de) - Moderna-Aktienanalyse von "Der Aktionär":
Michel Doepke vom Anlegermagazin "Der Aktionär" nimmt in einer aktuellen Aktienanalyse die Aktie von…
Apple, Nvidia, Intel, Coinbase and Moderna fall premarket…
Moderna plunges on downgrade amid vaccine headwinds…
Toronto (www.aktiencheck.de) - Rating-Update:
Die Analysten vom Investmenthaus RBC Capital Markets stufen die Aktie von Moderna Inc. (ISIN: US60770K1079, WKN: A2N9D9,…
Zürich (www.aktiencheck.de) - Rating-Update:
Die Analysten der UBS stufen die Aktie von Moderna Inc. (ISIN: US60770K1079, WKN: A2N9D9, Ticker-Symbol: 0QF, NASDAQ-Symbol:…
Charlotte (www.aktiencheck.de) - Moderna-Aktienanalyse von BofA Securities:
Die Analysten von BofA Securities stufen die Aktie von Moderna Inc. (ISIN: US60770K1079, WKN:…
Wall Street is reacting to the July jobs report. Economists had expected the economy to have added 175,000 jobs and…
…
MRNA earnings call for the period ending June 30, 2024.…
MRNA earnings call for the period ending June 30, 2024.…
Stocks that traded heavily or had substantial price changes on Thursday: Meta Platforms, Shake Shack rise; Moderna, Goodyear fall…
Moderna Inc (NASDAQ:MRNA, ETR:0QF) shares plummeted almost 20% after the vaccine maker slashed its full-year sales forecast for respiratory vaccines…
Moderna Inc (NASDAQ:MRNA, ETR:0QF) shares plummeted almost 20% after the vaccine maker slashed its full-year sales forecast for respiratory vaccines…
Kulmbach (www.aktiencheck.de) - Moderna-Aktienanalyse von "Der Aktionär":
Andreas Deutsch vom Anlegermagazin "Der Aktionär" nimmt in einer aktuellen Aktienanalyse die Aktie von…
Die jüngsten Quartalszahlen von Moderna haben zu einem signifikanten Kurssturz der Aktie geführt, nachdem das Unternehmen einen Verlust von 3,33…
Meta Platforms, Ferrari, ConocoPhillips rise premarket; Arm, Moderna fall…
Moderna cuts guidance on low EU sales, competitive vaccine environment in the U.S.…
Moderna now expects 2024 product revenue to come in between $3 billion and $3.5 billion, down from a previous guidance…
Moderna Inc.’s stock tumbled 12% premarket Thursday, after the biotech cut its sales guidance for 2024, offsetting a narrower-than-expected second-quarter...…
Moderna now expects 2024 product revenue to come in between $3 billion and $3.5 billion, down from a previous guidance…
Moderna reins in 2024 sales forecast, expects very low EU vaccine revenue…
Moderna (MRNA) beats expectations for earnings and sales. Management cuts sales guidance by $0.5-$1.0 billion on concerns about competition for…
NEW YORK, July 26, 2024 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of…
Investors will likely focus on updates on Modernas (MRNA) pipeline, especially its late-stage pipeline candidates when it reports second-quarter earnings.…
NEW YORK, July 20, 2024 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of…
Shares of Moderna (MRNA) continue to soar thanks to the encouraging development of its non-COVID pipeline. The companys potential product…
The biotech is proving that its not a pandemic stock.…
Biotech investor Flagship Pioneering has raised $3.6 billion dollars for ventures in health, sustainability and AI. With $14 billion dollars…
Microsoft and Apple dropped plans to take board roles at OpenAI in a surprise decision that underscores growing regulatory scrutiny of Big Tech’s…
Incubator Flagship Pioneering plans to finance and launch array of companies using AI for pharmaceutical development…
Top-ranked stocks Chewy (CHWY), Wingstop (WING), Moderna (MRNA), Tenet Healthcare (THC) and Kinross Gold (KGC) are likely to beat on…